Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramadevi Raghunandan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Malaria Journal|December 19, 2019
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stagesYevel Flores-Garcia, Sonia M Herrera, Hugo Jhun, et al.
Stem Cells and Development|June 3, 2008
Dlk1 influences differentiation and function of B lymphocytesRamadevi Raghunandan, Maria Ruiz-Hidalgo, Yifeng Jia, et al.
Vaccine|July 30, 2013
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virusGale E Smith, David C Flyer, Ramadevi Raghunandan, et al.
Journal of Virology|August 26, 2011
H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humansSurender Khurana, Jian Wu, Nitin Verma, et al.
Vaccine|August 6, 2011
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in MexicoConstantino López-Macías, Eduardo Ferat-Osorio, Alejandra Tenorio-Calvo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Malaria Journal|December 19, 2019
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stagesYevel Flores-Garcia, Sonia M Herrera, Hugo Jhun, et al.
Stem Cells and Development|June 3, 2008
Dlk1 influences differentiation and function of B lymphocytesRamadevi Raghunandan, Maria Ruiz-Hidalgo, Yifeng Jia, et al.
Vaccine|July 30, 2013
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virusGale E Smith, David C Flyer, Ramadevi Raghunandan, et al.
Journal of Virology|August 26, 2011
H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humansSurender Khurana, Jian Wu, Nitin Verma, et al.
Vaccine|August 6, 2011
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in MexicoConstantino López-Macías, Eduardo Ferat-Osorio, Alejandra Tenorio-Calvo, et al.
Pageof 1